Cargando…

Effects of Roxadustat on Erythropoietin Production in the Rat Body

Anemia is a major complication of chronic renal failure. To treat this anemia, prolylhydroxylase domain enzyme (PHD) inhibitors as well as erythropoiesis-stimulating agents (ESAs) have been used. Although PHD inhibitors rapidly stimulate erythropoietin (Epo) production, the precise sites of Epo prod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasuoka, Yukiko, Izumi, Yuichiro, Fukuyama, Takashi, Omiya, Haruki, Pham, Truyen D., Inoue, Hideki, Oshima, Tomomi, Yamazaki, Taiga, Uematsu, Takayuki, Kobayashi, Noritada, Shimada, Yoshitaka, Nagaba, Yasushi, Yamashita, Tetsuro, Mukoyama, Masashi, Sato, Yuichi, Wall, Susan M., Sands, Jeff M., Takahashi, Noriko, Kawahara, Katsumasa, Nonoguchi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838165/ https://www.ncbi.nlm.nih.gov/pubmed/35164384 http://dx.doi.org/10.3390/molecules27031119

Ejemplares similares

Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver
por: Yasuoka, Yukiko, et al.
Publicado: (2021)

Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting
por: Yasuoka, Yukiko, et al.
Publicado: (2020)

Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation
por: Yasuoka, Yukiko, et al.
Publicado: (2020)

Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue
por: Yasuoka, Yukiko, et al.
Publicado: (2023)

Effects of Atrial Natriuretic Peptide on Bicarbonate Transport in Long- and Short-Looped Medullary Thick Ascending Limbs of Rats
por: Nonoguchi, Hiroshi, et al.
Publicado: (2013)

TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct
por: Izumi, Yuichiro, et al.
Publicado: (2017)

Roxadustat for treatment of erythropoietin-hyporesponsive anemia in a hemodialysis patient: A case report
por: Yu, Wei-Hong, et al.
Publicado: (2020)

Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
por: Xu, Bojun, et al.
Publicado: (2021)

Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin
por: Yang, Xiaowei, et al.
Publicado: (2021)

Thyroid function analysis after roxadustat or erythropoietin treatment in patients with renal anemia: a cohort study
por: Zheng, Xiaomeng, et al.
Publicado: (2023)

Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study
por: Jin, Chen, et al.
Publicado: (2022)

Effect of Roxadustat versus erythropoietin (EPO) for treating anemia in patients with diabetic kidney disease: a retrospective cohort study
por: Zhang, Lei, et al.
Publicado: (2022)

Roxadustat: Not just for anemia
por: Zhu, Xiaoyu, et al.
Publicado: (2022)

Successful application of roxadustat in the treatment of patients with anti-erythropoietin antibody-mediated renal anaemia: a case report and literature review
por: Cai, Ke-Dan, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of Roxadustat
por: Czock, David, et al.
Publicado: (2021)

Comparison between the influence of roxadustat and recombinant human erythropoietin treatment on blood pressure and cardio-cerebrovascular complications in patients undergoing peritoneal dialysis
por: Cheng, Shuiqin, et al.
Publicado: (2023)

Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase
por: Yamazaki, Taiga, et al.
Publicado: (2017)

Two Phase 3 Studies on Ophthalmologic Effects of Roxadustat Versus Darbepoetin
por: Sepah, Yasir J., et al.
Publicado: (2022)

Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD
por: Akizawa, Tadao, et al.
Publicado: (2021)

Roxadustat and thyroid-stimulating hormone suppression
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021)

Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study
por: Zhang, Wei, et al.
Publicado: (2022)

Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome
por: Shimada, Yoshitaka, et al.
Publicado: (2017)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021)

Roxadustat: Do we know all the answers?
por: Li, Qiu-Yu, et al.
Publicado: (2023)

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones
por: Shimada, Yoshitaka, et al.
Publicado: (2018)

Radioprotective effects of roxadustat (FG‐4592) in haematopoietic system
por: Zhang, Pei, et al.
Publicado: (2018)

Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)

Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy
por: Zheng, Fangfang, et al.
Publicado: (2022)

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model
por: Uematsu, Takayuki, et al.
Publicado: (2023)

Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers
por: Shida, Akiko, et al.
Publicado: (2020)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
por: Hirai, Keiji, et al.
Publicado: (2023)

Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation
por: Zhao, Jiaxin, et al.
Publicado: (2021)

Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia
por: Zhu, Xin-Wang, et al.
Publicado: (2021)

The role of roxadustat in chronic kidney disease patients complicated with anemia
por: Liu, Jie, et al.
Publicado: (2023)

Retracted: Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Transfusion-dependent anaemia treatment using continuous erythropoietin receptor activator (epoetin β pegol) and roxadustat after darbepoetin treatment failure in low-risk myelodysplastic syndrome: a case report
por: Ikenoue, Tatsuyoshi, et al.
Publicado: (2021)

Characterization of IL-17-producing T helper cells-like autoreactive T cells in aged mice
por: Uematsu, Takayuki, et al.
Publicado: (2019)

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
por: Provenzano, Robert, et al.
Publicado: (2020)

A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study
por: Charytan, Chaim, et al.
Publicado: (2021)

Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
por: Ganz, Tomas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4s60bq73rdupkg12440kfd9tc